Filing Flows › BioScience Health Innovations (BHIC) › Q1 2026 › vs Q1 2025
BioScience Health Innovations (BHIC) Q1 2026 vs Q1 2025 (year over year)
BioScience Health Innovations's revenue fell $476K (-39%) from $1.2M in Q1 2025 to $751K in Q1 2026.
BioScience Health Innovations, Q1 2026: revenue $751K (-39% year over year), operating margin -30.6%, net loss $230K, operating cash flow −$552K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $751K | $1.2M | −$476K | -39% |
| Net loss | $230K | −$427K | $657K | — |
| Costs & expenses | $981K | $1.2M | −$246K | -20% |
| Operating costs | $981K | $800K | $181K | +23% |
| Cost of revenue | $265K | $331K | −$66K | -20% |
| Operating cash sources | $552K | −$328K | $880K | — |
| Cash used in operations | $552K | −$328K | $880K | — |
| Net loss absorbed | $230K | −$427K | $657K | — |
| Working capital & other | $322K | $98K | $224K | +227% |
Questions
How much did BioScience Health Innovations's revenue grow year over year in Q1 2026?
BioScience Health Innovations's revenue fell $476K (-39%) from $1.2M in Q1 2025 to $751K in Q1 2026.